Looking ahead, our ambition is to become #1 in brain health. We believe that to restore brain health we need to work in partnership in a multisectoral and multi-stakeholder approach. We will continue to focus on efforts in three priority areas:
Research and Medical Education
Fostered by a mindset of “drug hunger”, Lundbeck invests 415M EUR1 (close to 20% of ourrevenue) in brain research annually, we partner with leading research experts andcenters and we invest in medical education.
People with Lived Experience and Their Families
We ensure that we listen and integratepatient insights throughout Lundbeck’svalue-chain, we provide patient educationprograms, as well as innovative treatmentsalongside support programs.
Community and Society
We seek to empower the brain healthadvocacy community, we co-create andpublish evidence that fights stigma, and weadvocate for systemic change to improve thelives of people with brain health conditions. As an employer of 5,600 people worldwide, we have aresponsibility to promote wellbeing, train ouremployees and ensure a diverse and inclusiveworkplace, including of people impacted bybrain health conditions.
To become number #1 in Brain Health by 2030, so that we are well positioned to continue serving people with brain health conditions for years to come.
I have a saying I like to use which is, “we need every brain in the game.” What I mean by this is that we need diversity of thought and perspectives across everything that we do, because in the end that is what will make Lundbeck a better company and make us even more relevant for our patients.
The Lundbeck Magazine portrays true patient stories and reviews the discrimination surrounding people with brain diseases. It also tells the Lundbeck story and describes the pharmaceutical value chain.
At Lundbeck, we have a strong heritage within neuroscience, and we already have a solid track record of delivering innovative treatments to people living with brain diseases.